ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,049.88
0.05%
US Tech 100
20,718.80
0.52%
다우존스 지수
44,705.53
-0.17%
Bitcoin
96,576.92
0.63%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Maravai LifeSciences Holdings Inc (MRVI) 시세

Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

NASDAQ
5.40
-0.34
(-5.92%)
마감 04 12월 6:00AM
15분 지연
5.36
-0.04
(-0.74%)
시간외 거래: 9:08AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
5.36
매수가
5.36
매도가
5.57
거래량
1,114,784
5.36 일간 변동폭 5.71
4.275 52주 범위 11.555
market_cap
1.354B
전일 종가
5.74
개장가
5.71
최근 거래 시간
8400
@
5.36
(formt)
마지막 거래 시간
재정 규모
US$ 6,093,973
VWAP
5.4665
평균 볼륨(3m)
1,811,422
발행 주식
252,527,585
배당수익률
-
주가수익률
-11.48
주당순이익(EPS)
-0.47
매출
292.23M
순이익
-119.03M

Maravai LifeSciences Holdings Inc 정보

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Wilmington, Delaware, USA
설립됨
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker MRVI. The last closing price for Maravai LifeSciences was US$5.74. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 4.275 to US$ 11.555.

Maravai LifeSciences currently has 252,527,585 shares in issue. The market capitalisation of Maravai LifeSciences is US$1.45 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -11.48.

MRVI 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities

19 11월 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 11월 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 11월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 11월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 11월 2024
Edgar (US Regulatory)

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is...

12 11월 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

09 11월 2024
Edgar (US Regulatory)

Maravai LifeSciences plant die Übernahme des DNA- und RNA-Geschäfts von Officinae Bio und fördert damit die Unterstützung innovativer Nukleinsäureforschung

Durchbrüche von Officinae Bio bei KI-gestützten Methoden zur Nukleinsäureherstellung zur Verbesserung der mRNA-Herstellungskapazitäten von Maravai innerhalb des TriLink...

08 11월 2024
Business Wire

Maravai LifeSciences prévoit d’acquérir les activités ADN et ARN d’Officinae Bio afin de renforcer son soutien à la recherche innovante sur les acides nucléiques

Les percées d’Officinae Bio dans les méthodologies de fabrication d’acides nucléiques basées sur l’IA vont renforcer les capacités de fabrication d’ARNm de Maravai au sein de l’entreprise TriLink...

08 11월 2024
Business Wire

Form 8-K - Current report

08 11월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.112.095238095245.256.134.9620676095.73577434CS
4-2.26-29.65879265097.628.174.27527151465.50730116CS
12-3.53-39.70753655798.899.54.27518114226.81037329CS
26-3.51-39.5715896288.8710.034.27519948307.7912651CS
52005.3611.5554.27521783587.6581958CS
156-38.14-87.678160919543.544.244.275206787814.83278477CS
260-25.75-82.770813243331.1163.554.275191928819.64984803CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ZJKZJK Industrial Company Ltd
US$ 17.185
(171.06%)
28.21M
CTNTCheetah Net Supply Chain Service Inc
US$ 4.81
(157.22%)
113.16M
ORISOriental Rise Holdings Ltd
US$ 11.11
(69.10%)
1.47M
JYDJayud Global Logistics Ltd
US$ 1.1299
(68.62%)
10.8M
GWAVGreenwave Technology Solutions Inc
US$ 0.6078
(66.52%)
512.32M
REVBRevelation Biosciences Inc
US$ 0.504151
(-46.93%)
6.04M
OMEXOdyssey Marine Exploration Inc
US$ 0.4201
(-43.63%)
4.83M
RITRReitar Logtech Holdings Ltd
US$ 2.68
(-38.39%)
1.25M
XCURExicure Inc
US$ 14.05
(-37.00%)
428.68k
AGFYAgrify Corporation
US$ 32.72
(-36.69%)
283.41k
GWAVGreenwave Technology Solutions Inc
US$ 0.6078
(66.52%)
512.26M
SMCISuper Micro Computer Inc
US$ 40.21
(-4.26%)
200.61M
NVDANVIDIA Corporation
US$ 140.26
(1.18%)
162.81M
INTCIntel Corporation
US$ 22.47
(-6.10%)
135.91M
CHRSCoherus BioSciences Inc
US$ 1.7001
(24.09%)
113.52M

MRVI Discussion

게시물 보기
Monksdream Monksdream 9 월 전
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 9 월 전
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

최근 히스토리

NASDAQ
MRVI
Maravai LifeSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유